People: Competitive Technologies Inc (CTTC.PK)

CTTC.PK on OTC Markets Group

0.26USD
23 May 2013
Price Change (% chg)

$0.02 (+10.64%)
Prev Close
$0.23
Open
$0.26
Day's High
$0.26
Day's Low
$0.26
Volume
6,935
Avg. Vol
30,187
52-wk High
$1.24
52-wk Low
$0.20

Search Stocks

Summary

Name Age Since Current Position

Peter Brennan

 57 2012 Independent Chairman of the Board

Carl O'Connell

 2013 President, Chief Executive Officer, Director

Johnnie Johnson

 72 2012 Chief Financial Officer

Rustin Howard

 55 2012 Independent Director

Robert Moussa

 65 2012 Independent Director

Stanley Yarbro

 62 2012 Independent Director
» Insider Trading

Biographies

Name Description

Peter Brennan

 Mr. Peter F. Brennan, MBA, CFA, is Independent Chairman of the Board of Competitive Technologies, Inc. He holds MBA, CFA, and is a New York based investor who has worked over 30 years in the investment management business as an analyst and portfolio manager. In 2004 Mr. Brennan founded Damel Investors LLC, a private partnership which invests in small technology companies. Since 2005 Mr. Brennan has been a director and a member of the audit committee of Sonomax Technologies Inc., a Montreal based hearing healthcare company. From 1989 to 2007, Mr. Brennan co-founded MidCap Associates, Inc. and co-developed a low price/earnings equity product for institutional investors and managed a series of investment partnerships with Philip “Pete” Palmer. From 1998 to April 2002, Mr. Brennan was President of Noyes Partners Incorporated, a registered NASD broker-dealer which he joined in 1989. From 1987 to 1989, Mr. Brennan was assistant to the Senior Partner of Grayson, Burger & Company. His responsibilities included portfolio management, client contact and fundamental equity analysis. Mr. Brennan, from 1984 to 1987, was President of 44 Securities Inc., a registered broker-dealer. There he was responsible for trading and quantitative research analysis. From 1981 to 1984, he was a technology analyst at Schroder Capital Management. Concurrently, Mr. Brennan was Assistant Vice President of the Naess and Thomas Special Fund, a mutual fund specializing in emerging growth companies and special situations. Mr. Brennan received his MBA from the University of Chicago in 1979 and his BA from Haverford College in 1977. He is a member and past Chairman of the Corporate Governance Committee of the New York Society of Security Analysts. SA. Mr. Brennan was a member of the US Advocacy Committee of the CFA Institute and was a founding member of the Capital Markets Policy Council of the CFA Institute for Market Integrity, the global advocacy committee of the CFA Institute.

Carl O'Connell

 Mr. Carl O'Connell is President, Chief Executive Officer, Director of Competitive Technologies, Inc. He has a total 30 years of experience in the healthcare field and 20 years as a in the medical device arena. Prior to joining Competitive Technologies Mr. O'Connell held executive positions for top global medical device and fortune 500 companies. He recently served as President and CEO for the US Healthcare Division MedSurg for ITOCHU, a Japanese conglomerate, Vice President of Global Marketing for Stryker Spine, and President of Carl Zeiss Surgical. He is an experienced, driven executive with marketing and sales experience. Mr. O'Connell also has a proven track record in commercializing medical technologies as well as building effective and profitable sales and distribution organizations.

Johnnie Johnson

 Mr. Johnnie D. Johnson is Chief Financial Officer of Competitive Technologies, Inc. He resigned as Chief Executive Officer of the Company, effcetive November 1, 2012. Mr. Johnson brings over 30 years of experience to his role as Chief Executive Officer and Chief Financial Officer of Competitive Technologies. After obtaining his BS in Business and Accounting from University of Findlay in 1960 and his MBA from Bowling Green University in 1976, Mr. Johnson went to work with the original Marathon Oil Company (a Fortune 40 company) in 1960, where he remained until Marathon was acquired by USX in 1982. At Marathon, Mr. Johnson undertook numerous positions, including Auditor, Controller, and finally Assistant to the President and CEO where he was responsible for investor relations, crude oil trading, liaison activities with other operation components of Marathon and merger/acquisition coordination. While at Marathon Oil, he was singled out by Institutional Investor magazine as one of the foremost practitioners of investor relations in the US. From 1982 to 1986, after its acquisition of Marathon, Mr. Johnson joined USX (formerly US Steel and a Fortune 20 company), where as Assistant Corporate Comptroller he was responsible for investor relations and strategic planning. From 1986 to 1991, Mr. Johnson was Managing Director of Georgeson & Co., an investor relations, proxy solicitation, and shareholder analysis firm with 160 employees. Mr. Johnson served as chairman and CEO for seven years of Johnnie D. Johnson & Co., an investor relations firm from 1991 to 1998, serving over 150 clients. Most recently, Mr. Johnson has assisted CTTC in his role as Chief Executive Officer of IR Services, LLC (previously Strategic IR, Inc.), beginning in 1998 through present. Mr. Johnson is a graduate of Harvard’s Advanced Management Program, and was previously a licensed CPA.

Rustin Howard

 Mr. Rustin R. Howard is Independent Director of Competitive Technologies, Inc. He served as Independent Chairman of the Board of the Company until May 24, 2012. Mr. Howard is principal of Whitesand Investments LLC, an angel investment organization. In 1990, he founded and served as CEO and Chairman of Phyton, Inc., the use of proprietary plant cell fermentation technology, including the production of paclitaxel, the active ingredient of Bristol-Myers Squibb's multi-billion dollar anticancer drug, Taxol®. Phyton was sold to DFB Pharmaceuticals, Inc. in 2003. Additionally, Mr. Howard is the Chairman of DeepGulf, Inc., and a co-owner and officer of Silver Bullet Technology. DeepGulf builds underwater pipelines and associated facilities in deep and ultra-deep offshore oil and gas production fields. Silver Bullet Technology, where he has been primarily responsible for corporate and financial oversight as well as strategic planning, manufactures and sells software for the banking and payment processing industry. Previously, he served as president and CEO of BioWorks Inc., a biotechnology company he founded to develop, produce, and sell products that replace chemical pesticides. Mr. Howard earned his MBA from Cornell University's Johnson Graduate School of Management, where he focused his studies on entrepreneurship, and managing innovation and technology.

Robert Moussa

 Mr. Robert G. Moussa is Independent Director of Competitive Technologies, Inc. He currently serves as Chairman, President, and Chief Executive Officer of Dilon Diagnostics, having spent more than 30 years in the healthcare field. In addition to his role at Dilon, he has held a number of senior positions at both Sherwood Medical Industries and Mallinckrodt Medical. Mr. Moussa has experience launching new products in the diagnostic, nuclear medicine and medical device markets. Before joining Dilon Technologies, Inc., Mr. Moussa served as President and Chief Executive Officer of Robert Moussa & Associates, a consulting firm serving the pharmaceutical, biotechnology and healthcare industries. Prior to founding this firm, he served in a variety of executive positions with Mallinckrodt, Inc., St. Louis, Missouri, a $2.4 billion healthcare and chemical company. Mr. Moussa's most recent assignment at Mallinckrodt was President - International, a position he held from 1995 through 1997. Previously he served as President and Chief Executive Officer - Mallinckrodt Medical, Inc., Mallinckrodt's business unit with over $1 billion dollars in revenues (1992-1996). Before joining Mallinckrodt Medical in 1992, Mr. Moussa served as Mallinckrodt, Inc.'s Group Vice President - International Medical Products, Vice President and General Manager - Medical Products Europe, General Manager of Critical Care, Director of Business Operations and General Sales Manager. Prior to joining Mallinckrodt, Mr. Moussa held a number of positions during the period 1969 through 1976 with Sherwood Medical, United Kingdom, most recently as Director of Marketing. Mr. Moussa received his Baccalaureate from the Collge du Sacre-Cur, Beirut, Lebanon, in 1966 and his Bachelor of Science in Business Administration from Ealing University, London, England, in 1969. He has also completed executive seminars at the University of California at Berkley, the Aspen Institute, the Wharton Executive School and the Center for Creative Leadership.

Stanley Yarbro

 Dr. Stanley K. Yarbro, Ph.D., is Independent Director of Competitive Technologies, Inc. He has experience in market development of high technology solutions to a worldwide customer base. He recently retired as Executive Vice President, Worldwide Field Operations, for Varian Semiconductor Equipment Associates, a position he had held since 2004. Prior to Varian, Dr. Yarbro served in various executive capacities at KLA-Tencor Corporation, in the semi-conductor industry. He currently serves on the boards of FSI International and Carbon Design Innovations and has previously served on the boards of Electrogas, Inc. and Molecular Imaging where he worked closely with the organizations to develop and improve sales and marketing strategies. Dr. Yarbro holds a Ph.D. in Analytical Chemistry from Georgia Institute of Technology and a B.S.in Chemistry from Wake Forest University.

Basic Compensation

Name Fiscal Year Total

Peter Brennan

 --

Carl O'Connell

 --

Johnnie Johnson

 --

Rustin Howard

 --

Robert Moussa

 --

Stanley Yarbro

 --
As Of 

Options Compensation

Name Options Value

Peter Brennan

 0 0

Carl O'Connell

 0 0

Johnnie Johnson

 0 0

Rustin Howard

 0 0

Robert Moussa

 0 0

Stanley Yarbro

 0 0

Insider Trading

Name Shares Traded Price

BRENNAN PETER F

 2,500 $0.00

EVANS JOEL M

 2,500 $0.00

REALI WILLIAM L

 2,500 $0.00

HOWARD RUSTIN R

 5,000 $0.00

HORNIDGE RICHARD D JR

 5,000 $0.00

BRENNAN PETER F

 121,960 $0.47

BRENNAN PETER F

 121,960 $0.47

HORNIDGE RICHARD D JR

 2,500 $0.59

YARBRO STANLEY

 5,000 $0.85

YARBRO STANLEY

 3,000 $0.93

HOWARD RUSTIN R

 3,500 $0.95

HOWARD RUSTIN R

 1,500 $0.98

HOWARD RUSTIN R

 4,255 $1.41

EVANS JOEL M

 4,964 $1.41

REALI WILLIAM L

 2,500 $0.00

HOWARD RUSTIN R

 2,500 $0.00

EVANS JOEL M

 2,500 $0.00

HORNIDGE RICHARD D JR

 2,500 $0.00
» Full list on Insider Trading
Search Stocks